Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2023-04-28 00:00:00 ET · period of report 2023-04-26 · accession 0001171843-23-002685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-28 | 2023-04-26 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +24.6K | 125.2K | +24% | $0 |
| D | 2023-04-28 | 2023-04-26 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $26.34 | -10.9K | 114.3K | -9% | -$287.1K |
| D | 2023-04-28 | 2023-04-26 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | -24.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-26 | M | A | 24,575 | $0.00 | 125,155 | D | — | — | (F1) Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on April 26, 2020. |
| 2 | Common | Common Stock | 2023-04-26 | F | D | 10,900 | $26.34 | 114,255 | D | — | — | (F2) Reflects an aggregate of 10,900 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on April 26, 2023. (F3) Reflects the closing price of ANIK common stock on April 26, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| 3 | Derivative | Restricted Stock Unit | 2023-04-26 | M | D | 24,575 | $0.00 | 0 | D | $0.00 · — to — | 24,575 Common Stock | (F5) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning April 26, 2021. |